NCT06688097

Brief Summary

A total of 103 elective surgery patients who met the inclusion criteria were selected. After screening for eligibility according to the inclusion and exclusion criteria and signing informed consent, they were randomly divided into two groups. Upon entering the operating room, routine ECG monitoring was initiated, and a peripheral vein was opened. Ultrasound was used to measure the baseline cross-sectional area (CSA) of the gastric antrum in the supine position. After general anesthesia induction, positive pressure ventilation was applied via face mask. Group A received no external compression, while Group B underwent esophageal compression under ultrasound guidance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 25, 2024

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 14, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

12 months

First QC Date

October 15, 2024

Last Update Submit

April 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of gastric distension

    Defined as a significant increase in gastric antrum CSA with acoustic shadowing or the characteristic "comet-tail sign," or when the enlarged gastric antrum obstructs the surgical field

    During anesthesia induction

Secondary Outcomes (8)

  • The positional relationship between the esophagus and trachea

    Before anesthesia induction

  • Tidal volume

    During anesthesia induction

  • Oxygen saturation

    During anesthesia induction

  • Airway plateau

    During anesthesia induction

  • The percentage of glottic opening (POGO) score

    During tracheal intubation, immediately

  • +3 more secondary outcomes

Study Arms (2)

Group A (Control Group)

NO INTERVENTION

No esophageal compression is applied, and FMV is performed for 4 minutes.

Group B (Intervention Group)

EXPERIMENTAL

Ultrasound-guided esophageal compression plus FMV: before the start of FMV, ultrasound is used to locate the esophagus, and pressure is applied to the esophagus at the cricoid level to collapse the esophageal lumen. Esophageal pressure is released just before tracheal intubation following 4 minutes of ventilation.

Behavioral: Compression of esophageal

Interventions

Before the start of FMV, ultrasound is used to locate the esophagus, and pressure is applied to the esophagus at the cricoid level to collapse the esophageal lumen. Esophageal pressure is released just before tracheal intubation following 4 minutes of ventilation.

Group B (Intervention Group)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 65 years
  • American Society of Anesthesiologists (ASA) Physical Status Classification I-II.
  • Body Mass Index (BMI) between 18 and 28 kg/m².
  • Patients undergoing elective tracheal intubation for general anesthesia.
  • Patients scheduled for laparoscopic surgery.
  • Fasting for ≥8 hours and abstaining from liquids for ≥2 hours before surgery, with low risk of gastroesophageal regurgitation and aspiration.

You may not qualify if:

  • Suspected difficult FMV (e.g., age \>55 years, BMI \>26 kg/m², edentulous, history of snoring, and long beard; presence of two or more factors).
  • Pre-existing respiratory, pharyngeal, laryngeal, facial, or neck pathology.
  • History of gastrointestinal surgery, gastroesophageal reflux disease (GERD), or high risk of aspiration.
  • Severe cardiac, cerebral, pulmonary, hepatic, or renal diseases.
  • Patients requiring non-invasive ventilation prior to surgery.
  • Patients currently participating in other clinical trials or who refuse to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing First Hospital

Nanjing, Jiangsu, 210006, China

Location

MeSH Terms

Conditions

Gastric Dilatation

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director, Department of Anesthesia, Pain and Perioperative Medicine

Study Record Dates

First Submitted

October 15, 2024

First Posted

November 14, 2024

Study Start

September 25, 2024

Primary Completion

September 12, 2025

Study Completion

December 31, 2025

Last Updated

April 24, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations